Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetes

Melanie Heinrich1, Nicole Maison1, Peter Achenbach1

  • 1Institute of Diabetes Research, Helmholtz Zentrum München, Munich, Germany, and Forschergruppe Diabetes der Technischen Universität München, Munich, Germany.

Pediatric Diabetes
|August 12, 2018
PubMed

Insights

Fasting hypoglycemia in children with presymptomatic type 1 diabetes may signal disease progression. This finding suggests hypoglycemia could be a new marker for identifying children needing closer monitoring for type 1 diabetes development.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Immunology

Background:

  • Presymptomatic type 1 diabetes in children is characterized by hyperglycemia and rising HbA1c.
  • Hypoglycemia has been anecdotally reported in presymptomatic type 1 diabetes.

Purpose of the Study:

  • To investigate the prevalence of hypoglycemia in children with presymptomatic type 1 diabetes.
  • To determine if hypoglycemia is associated with disease progression.

Main Methods:

  • Compared fasting glucose levels in autoantibody-negative and autoantibody-positive children (ages 2-5).
  • Categorized autoantibody-positive children into hypoglycemic, normoglycemic, or hyperglycemic fasting groups.
  • Assessed glucose response during oral glucose tolerance tests (OGTTs).

Main Results:

  • 5.1% of autoantibody-positive children had fasting hypoglycemia; none in autoantibody-negative group.
  • Fasting hypoglycemia was more frequent in later stages (2-3) of type 1 diabetes progression (P=0.02).
  • Hypoglycemic children showed higher 120-minute OGTT glucose levels and more pathological OGTTs (P=0.04).

Conclusions:

  • Fasting hypoglycemia may indicate disease progression in presymptomatic type 1 diabetes.
  • Hypoglycemia could serve as a novel marker for closer monitoring of disease progression.
  • Identifies children at higher risk for developing insulin-dependent type 1 diabetes.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
992
Piaget's Stage 1 of Cognitive Development01:14

Piaget's Stage 1 of Cognitive Development

The sensorimotor stage, the initial phase of Jean Piaget's theory of cognitive development, spans the first two years of a child's life. During this period, infants actively engage with their surroundings, building cognitive awareness through direct interaction with the world. This interaction is primarily based on sensory perception and motor actions, allowing infants to gradually understand basic physical properties and predict how objects interact within their environment.
Exploration...
1.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K